BRCA1 and breast cancer: As there is widespread agreement that only about 16% of heritable breast and ovarian cancer risk is attributable to the high-penetrance BRCA1/2 mutations [12,13], it seems likely that many BC cases in BRCA1/2-negative families could be attributable to moderate- or low-penetrance genes [14].